当前位置: X-MOL 学术J. Natl. Cancer Inst. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results
Journal of the National Cancer Institute ( IF 10.3 ) Pub Date : 2018-02-27 , DOI: 10.1093/jnci/djy015
Angela R Bradbury 1 , Linda J Patrick-Miller 2 , Brian L Egleston 3 , Michael J Hall 3 , Susan M Domchek 1 , Mary B Daly 3 , Pamela Ganschow 4 , Generosa Grana 5 , Olufunmilayo I Olopade 2 , Dominique Fetzer 1 , Amanda Brandt 1 , Rachelle Chambers 2 , Dana F Clark 5 , Andrea Forman 3 , Rikki Gaber 4 , Cassandra Gulden 2 , Janice Horte 5 , Jessica M Long 1 , Terra Lucas 4 , Shreshtha Madaan 2 , Kristin Mattie 5 , Danielle McKenna 1 , Susan Montgomery 3 , Sarah Nielsen 2 , Jacquelyn Powers 1 , Kim Rainey 3 , Christina Rybak 3 , Michelle Savage 3 , Christina Seelaus 4 , Jessica Stoll 2 , Jill E Stopfer 1 , Xinxin (Shirley) Yao 5
Affiliation  

Germline genetic testing is standard practice in oncology. Outcomes of telephone disclosure of a wide range of cancer genetic test results, including multigene panel testing (MGPT) are unknown.

中文翻译:

电话与非公开的非劣效性试验对生殖细胞癌基因测试结果的个人披露

生殖系基因测试是肿瘤学的标准做法。电话公开各种癌症基因测试结果的结果,包括多基因面板测试(MGPT),尚不清楚。
更新日期:2018-02-27
down
wechat
bug